Literature DB >> 23105774

Biochemical parameters in neuroblastoma.

S T Bolkar1, M S Ghadge, A S Raste.   

Abstract

Apart from the biochemical parameters routinely used like Vanillyl Mandellic Acid for the patients with neuroblastoma the parameters like neuron specific enolase, ferritin, lactate dehydrogenase, gamma glutamyl transferase were also studied to assess the utility in diagnosing the patients with neuroblastoma. The study involved 40 healthy ambulatory subjects and 30 untreated cases of histologically proved neuroblastoma referred to the Tata Memorial Hospital for further management and treatment. The urinary Vanillyl Mandellic Acid levels and the serum levels of neuron specific enolase, ferritin, lactate dehydrogenase had increased significantly, p<0.001 whereas the gamma glutamyl transferase had decreased significantly p<0.001, as compared to the normal. Serum neuron specific enolase, ferritin, lactate dehydrogenase alongwith urinary Vanillyl Mandellic Acid could be of help in diagnosing the patients with neuroblastoma.

Entities:  

Keywords:  Biochemical Parameters; Neuroblastoma; Neuron Specific Enolase; Vanillyl Mandellic Acid

Year:  2008        PMID: 23105774      PMCID: PMC3453444          DOI: 10.1007/s12291-008-0066-7

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  8 in total

1.  A kinetic photometric method for serum gamma-glutamyl transpeptidase.

Authors:  G Szasz
Journal:  Clin Chem       Date:  1969-02       Impact factor: 8.327

2.  Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors.

Authors:  E H LaBrosse; C Com-Nougué; J M Zucker; E Comoy; C Bohuon; J Lemerle; O Schweisguth
Journal:  Cancer Res       Date:  1980-06       Impact factor: 12.701

3.  Screening for neuroblastoma in France: methodological aspects and preliminary observations.

Authors:  F Chauvin; P Mathieu; D Frappaz; C Lasset; M C Favrot; J Greffe; J Esteve; P Thiesse; V Combaret; P Chauvot; R Boschetti; L David; M Brunat-Mentigny; T Philip
Journal:  Med Pediatr Oncol       Date:  1997-02

4.  High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.

Authors:  Y Ishiguro; K Kato; A Shimizu; T Ito; M Nagaya
Journal:  Clin Chim Acta       Date:  1982-05-20       Impact factor: 3.786

5.  Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.

Authors:  D N Carney; P J Marangos; D C Ihde; P A Bunn; M H Cohen; J D Minna; A F Gazdar
Journal:  Lancet       Date:  1982-03-13       Impact factor: 79.321

6.  Neuron-specific enolase is produced by neuroendocrine tumours.

Authors:  F J Tapia; J M Polak; A J Barbosa; S R Bloom; P J Marangos; C Dermody; A G Pearse
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

7.  Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases.

Authors:  F Berthold; R Trechow; S Utsch; J Zieschang
Journal:  Am J Pediatr Hematol Oncol       Date:  1992-08

8.  Treatment of stage 4s neuroblastoma--report of 10 years' experience of the French Society of Paediatric Oncology (SFOP).

Authors:  G Schleiermacher; H Rubie; O Hartmann; C Bergeron; P Chastagner; F Mechinaud; J Michon
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.